Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Advani
Clinical Activity of Regn1979, an Anti-Cd20 X Anti-Cd3 Bispecific Antibody (Ab) in Patients (Pts) With (W/) Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response to A+chp by Cd30 Expression in the Echelon-2 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (Aitl) and Cxcl12+ Peripheral T-Cell Lymphoma (Ptcl): Preliminary Results From a Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bet Inhibitor Rg6146, Venetoclax, and Rituximab Is a Highly Active Regimen in Relapsed/Refractory (R/R) Dlbcl: Initial Report of Phase 1b Safety, Biomarker, and Response Data
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response to Brentuximab Vedotin by Cd30 Expression: Results From Five Trials in Ptcl, Ctcl, and B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ibrutinib Monotherapy Produces Long-Term Disease Control in Previously Treated Waldenstrom's Macroglobulinemia. Final Report of the Pivotal Trial (Nct01614821).
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248
Clinical Cancer Research
Cancer Research
Oncology
Demonstration of Microwave Generation by a Ferroelectric-Cathode Tube
Applied Physics Letters
Astronomy
Physics
